PSYCHIATRIC AND PHYSICAL ILLNESS, SOCIODEMOGRAPHIC CHARACTERISTICS, AND THE USE OF PSYCHOTROPIC-DRUGS IN THE COMMUNITY - RESULTS FROM THE UPPER BAVARIAN FIELD-STUDY

被引:47
作者
WEYERER, S
DILLING, H
机构
[1] UNIV MUNICH,DEPT PSYCHIAT,W-8000 MUNICH 2,GERMANY
[2] MED UNIV LUBECK,DEPT PSYCHIAT,LUBECK,GERMANY
关键词
PSYCHOTROPIC DRUG USE; GENERAL POPULATION SAMPLE; PSYCHIATRIC AND PHYSICAL ILLNESS; SOCIODEMOGRAPHIC CHARACTERISTICS; USE OF MEDICAL SERVICES;
D O I
10.1016/0895-4356(91)90042-8
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In the Upper Bavarian Field Study a total of 1536 persons (15 years and older) were interviewed by research psychiatrists. 8.1% of all respondents took a psychotropic drug during the 7 days prior to the interview. The consumption rate among women was about three times as high as that for men. The use of psychotropic drugs increased with age. No consistent pattern was found with respect to social class. According to psychiatric/physical health status the highest consumption rate (29.4%) was found among those suffering solely from psychiatric disorders. The simultaneous occurrence of both psychiatric and physical disorder did not increase the risk of drug taking (21.4%). Less than 5% of the healthy respondents and of those suffering solely from a physical disorder used psychotropic drugs. A large proportion (63.0%) of those with previous psychiatric in- and outpatient treatment received psychotropic medication, as well as those suffering from schizophrenia (66.7%), affective psychoses (52.6%) and anxiety disorders (50.0%). The higher consumption of psychotropic drugs among women could not be explained by higher psychiatric or physical morbidity or the fact that women consult primary care physicians more frequently than do men. Controlling for co-morbidity and annual consultation of family physicians, significant sex differences in the consumption of psychotropic drugs persist.
引用
收藏
页码:303 / 311
页数:9
相关论文
共 39 条
[1]  
Anderson R M, 1980, J R Coll Gen Pract, V30, P609
[2]   CROSS-NATIONAL STUDY OF EXTENT OF ANTIANXIETY SEDATIVE DRUG-USE [J].
BALTER, MB ;
LEVINE, J ;
MANHEIMER, DI .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (14) :769-774
[3]   SOMATIC PRESENTATION OF DSM-III PSYCHIATRIC-DISORDERS IN PRIMARY CARE [J].
BRIDGES, KW ;
GOLDBERG, DP .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 1985, 29 (06) :563-569
[4]  
CAFFERATA GL, 1983, 14 NAT CTR HLTH DAT
[5]  
CHAMBERS CD, 1975, CHEM COPING REPORT L
[6]   MOOD-MODIFYING DRUGS PRESCRIBED IN A CANADIAN CITY - HIDDEN PROBLEMS [J].
COOPERSTOCK, R ;
SIMS, M .
AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1971, 61 (05) :1007-+
[7]   RESEARCH ON PSYCHOTROPIC-DRUG USE - A REVIEW OF FINDINGS AND METHODS [J].
COOPERSTOCK, R ;
PARNELL, P .
SOCIAL SCIENCE & MEDICINE, 1982, 16 (12) :1179-1196
[8]   PREVALENCE OF MENTAL-DISORDERS IN THE SMALL-TOWN - RURAL REGION OF TRAUNSTEIN (UPPER BAVARIA) [J].
DILLING, H ;
WEYERER, S .
ACTA PSYCHIATRICA SCANDINAVICA, 1984, 69 (01) :60-79
[9]  
Dohrenwend BP, 1969, SOCIAL STATUS PSYCHO
[10]  
Dunnell Karen, 1972, MED TAKERS PRESCRIBE